Table 2.
Trend in absolute numbers and percentages of AT, T and A
| |
Study year |
P* |
||||
|---|---|---|---|---|---|---|
| 2002 | 2004 | 2006 | 2008 | Total 2002-2008 | ||
|
AT |
|
|
|
|
|
|
| < 5 FEART without NRO |
56 (2.3%) |
47 (2.0%) |
43 (1.8%) |
44 (2.0%) |
190 (2.0%) |
0.539 |
| < 5 FEART with NRO |
855 (34.5%) |
955 (41.3%) |
914 (37.5%) |
809 (36.1%) |
3533 (37.3%) |
1 |
| ≥ 5 FEART without NRO |
344 (13.9%) |
309 (13.4%) |
268 (11.0%) |
235 (10.5%) |
1156 (12.2%) |
0.010 |
| ≥ 5 FEART with NRO |
990 (40.0%) |
779 (33.7%) |
984 (40.4%) |
920 (41.0%) |
3673 (38.8%) |
0.637 |
| GABHS infection |
233 (9.4%) |
223 (9.6%) |
227 (9.3%) |
234 (10.4%) |
917 (9.7%) |
0.553 |
|
Total AT |
2478 |
2313 |
2436 |
2242 |
9469 |
0.307 |
|
(100%) |
(100%) |
(100%) |
(100%) |
(100%) |
||
|
T |
|
|
|
|
|
|
| < 5 FEART without NRO |
6 (4.3%) |
24 (10.9%) |
9 (4.8%) |
3 (1.8%) |
42 (5.9%) |
0.605 |
| < 5 FEART with NRO |
9 (6.5%) |
25 (11.3%) |
23 (12.4%) |
20 (11.8%) |
77 (10.8%) |
0.132 |
| ≥ 5 FEART without NRO |
72 (52.2%) |
106 (48.0%) |
74 (39.8%) |
71 (42.0%) |
323 (45.2%) |
0.109 |
| ≥ 5 FEART with NRO |
40 (29.0%) |
46 (20.8%) |
58 (31.2%) |
65 (38.5%) |
209 (29.3%) |
0.317 |
| GABHS infection |
11 (8.0%) |
20 (9.0%) |
22 (11.8%) |
10 (5.9%) |
63 (8.8%) |
0.845 |
|
Total T |
138 |
221 |
186 |
169 |
714 |
0.784 |
| (100%) |
(100%) |
(100%) |
(100%) |
(100%) |
||
|
Total AT+T |
2616 (100%) |
2534 |
2622 |
2411 |
10183 |
0.309 |
| (100%) |
(100%) |
(100%) |
(100%) |
(100%) |
|
|
|
A |
|
|
|
|
|
|
| < 5 FEART without NRO |
285 (21.9%) |
237 (20.4%) |
293 (28.1%) |
265 (24.6%) |
1080 (23.5%) |
0.373 |
| < 5 FEART with NRO |
379 (29.1%) |
282 (24.3%) |
254 (24.3%) |
277 (25.7%) |
1192 (26.0%) |
0.508 |
| ≥ 5 FEART without NRO |
25 (1.9%) |
17 (1.5%) |
9 (0.9%) |
13 (1.2%) |
64 (1.4%) |
0.225 |
| ≥ 5 FEART with NRO |
241 (18.5%) |
259 (22.3%) |
236 (22.6%) |
211 (19.6%) |
947 (20.6%) |
0.592 |
| NRO |
373 (28.6%) |
367 (31.6%) |
252 (24.1%) |
312 (28.9%) |
1304 (28.4%) |
0.689 |
|
Total A |
1303 |
1162 |
1044 |
1078 |
4587 |
0.113 |
| (100%) | (100%) | (100%) | (100%) | (100%) | ||
AT = Adeno-Tonsillectomy; T = Tonsillectomy; A= Adenoidectomy; FEART = Feverish Episodes due to Acute Recurrent Tonsillitis; NRO = Nasal Respiratory Obstruction. GABHS = Group A β Hemolytic Streptococcus.